Clinical Trial Update: Surgicel Reduces Ovarian Endometriomas Recurrence [Phase 2]

View source ↗

Summary

Phase 2 trial update indicates Surgicel reduces recurrence of ovarian endometriomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrioma
• Ovarian Endometriosis

Drugs mentioned

• Surgicel (oxidized regenerated cellulose)

Snippet

Sponsor: Cairo University | Conditions: Endometrioma | Phase 2 | Status: COMPLETED